CIK 0001582313 · Large accelerated filer
Xenon Pharmaceuticals Inc.
Sign in to watch- Ticker
- XENE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- EIN
- 980661854
- Phone
- (604) 484-3300
- Business address
- 200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
- Open-market buys, last 90 days
- $1,681,140
- in 2 filings
- Open-market sales, last 90 days
- $425,829
- in 1 filing, $426K under 10b5-1 plans
Net +$1,255,311. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-13 | PATOU GARY Director | Option exercise · Stock Option (Right to Buy) | −2,800 | 0 | ||
| 2023-12-13 | PATOU GARY Director | Option exercise · Stock Option (Right to Buy) | −5,144 | 0 | ||
| 2023-08-24 | Svoronos Dawn Director | Sale | −25,000 | $38.70 | $968K | 25,000 |
| 2023-08-10 | Gover Justin D. Director | Grant or award · Stock Option (Right to Buy) | +28,000 | 28,000 | ||
| 2023-08-10 | Cannon Gillian Director | Grant or award · Stock Option (Right to Buy) | +28,000 | 28,000 | ||
| 2023-06-02 | AZAB MOHAMMAD Director | Grant or award · Stock Option (Right to Buy) | +18,475 | 18,475 | ||
| 2023-06-02 | PATOU GARY Director | Grant or award · Stock Option (Right to Buy) | +18,475 | 18,475 | ||
| 2023-06-02 | GANNON STEVEN Director | Grant or award · Stock Option (Right to Buy) | +18,475 | 18,475 | ||
| 2023-06-02 | Svoronos Dawn Director | Grant or award · Stock Option (Right to Buy) | +18,475 | 18,475 | ||
| 2023-06-02 | GAROFALO ELIZABETH A. Director | Grant or award · Stock Option (Right to Buy) | +18,475 | 18,475 | ||
| 2023-06-02 | PIMSTONE SIMON N. Director | Grant or award · Stock Option (Right to Buy) | +18,475 | 18,475 | ||
| 2023-06-02 | Machado Patrick Director | Grant or award · Stock Option (Right to Buy) | +18,475 | 18,475 | ||
| 2023-06-01 | PIMSTONE SIMON N. Director | Option exercise | +9,318 | $7.69 | $72K | 15,318 |
| 2023-06-01 | PIMSTONE SIMON N. Director | Shares withheld for taxes | −1,860 | $38.53 | $72K | 13,458 |
| 2023-06-01 | PIMSTONE SIMON N. Director | Sale | −7,458 | $38.97 | $291K | 6,000 |
| 2023-06-01 | PIMSTONE SIMON N. Director | Option exercise | +45,000 | $17.76 | $799K | 51,000 |
| 2023-06-01 | PIMSTONE SIMON N. Director | Shares withheld for taxes | −20,745 | $38.53 | $799K | 30,255 |
| 2023-06-01 | PIMSTONE SIMON N. Director | Sale | −24,255 | $38.78 | $941K | 6,000 |
| 2023-06-01 | PIMSTONE SIMON N. Director | Option exercise · Stock Option (Right to Buy) | −9,318 | 30,682 | ||
| 2023-06-01 | PIMSTONE SIMON N. Director | Option exercise · Stock Option (Right to Buy) | −45,000 | 0 |
Page 11 of 16 · 308 trades